BACKGROUND AND PURPOSE: Abdominal (chemo-)radiotherapy is associated with dose-limiting toxicity of various normal structures. The purpose of this retrospective study was to investigate radiation-induced changes of the spleen and their clinical consequences. PATIENTS AND METHODS: In gastric cancer patients treated with postoperative chemoradiotherapy, the spleen size and its functions were assessed at follow-up by spleen volume on CT-scan, serum leucocytes/thrombocytes, and the occurrence of infectious events consisting of pneumonia and fatal sepsis. To evaluate the effect of radiation dose, mixed effects and Cox regression models were used. RESULTS: Forty-six out of 90 consecutive patients treated from 2006 to 2011 were evaluable. All patients received 45 Gy in 25 fractions with concurrent capecitabine (n=8), and capecitabine/cisplatin (n=38). Median Dmean to the spleen was 40 Gy (range 32-46). Mean relative spleen volume reduced to 37% (95% CI 32-42%) at 4-year follow-up, which was most strongly associated to the V44 (p<0.001). Median follow-up time was 67 (95% CI 57-78) months. Eleven patients had 13 pneumonias and 3 fatal sepsis. No association with dosimetric parameters was observed. CONCLUSIONS: In postoperative chemoradiotherapy for gastric cancer, the spleen received a high radiation dose. This resulted in a progressive, radiation dose-dependent reduction of spleen volume. Pneumonia and fatal sepsis occurred frequently, possibly as a result of functional hyposplenia.
BACKGROUND AND PURPOSE: Abdominal (chemo-)radiotherapy is associated with dose-limiting toxicity of various normal structures. The purpose of this retrospective study was to investigate radiation-induced changes of the spleen and their clinical consequences. PATIENTS AND METHODS: In gastric cancerpatients treated with postoperative chemoradiotherapy, the spleen size and its functions were assessed at follow-up by spleen volume on CT-scan, serum leucocytes/thrombocytes, and the occurrence of infectious events consisting of pneumonia and fatal sepsis. To evaluate the effect of radiation dose, mixed effects and Cox regression models were used. RESULTS: Forty-six out of 90 consecutive patients treated from 2006 to 2011 were evaluable. All patients received 45 Gy in 25 fractions with concurrent capecitabine (n=8), and capecitabine/cisplatin (n=38). Median Dmean to the spleen was 40 Gy (range 32-46). Mean relative spleen volume reduced to 37% (95% CI 32-42%) at 4-year follow-up, which was most strongly associated to the V44 (p<0.001). Median follow-up time was 67 (95% CI 57-78) months. Eleven patients had 13 pneumonias and 3 fatal sepsis. No association with dosimetric parameters was observed. CONCLUSIONS: In postoperative chemoradiotherapy for gastric cancer, the spleen received a high radiation dose. This resulted in a progressive, radiation dose-dependent reduction of spleen volume. Pneumonia and fatal sepsis occurred frequently, possibly as a result of functional hyposplenia.
Authors: Vanessa Bellat; Richard Ting; Teresa L Southard; Linda Vahdat; Henrik Molina; Joseph Fernandez; Omer Aras; Tracy Stokol; Benedict Law Journal: Adv Funct Mater Date: 2018-09-14 Impact factor: 18.808
Authors: Brent R Weil; Arin L Madenci; Qi Liu; Rebecca M Howell; Todd M Gibson; Yutaka Yasui; Joseph P Neglia; Wendy M Leisenring; Susan A Smith; Emily S Tonorezos; Danielle N Friedman; Louis S Constine; Christopher L Tinkle; Lisa R Diller; Gregory T Armstrong; Kevin C Oeffinger; Christopher B Weldon Journal: J Clin Oncol Date: 2018-04-17 Impact factor: 44.544
Authors: Fernando P de Faria; Andy Petroianu; Paula P Campos; Marcela G T de Lazari; Jony M Geraldo; Clara B Nascimento; Sávio L Siqueira Journal: Heliyon Date: 2020-09-15
Authors: Melissa Lumish; Lorenzo Falchi; Brandon S Imber; Michael Scordo; Gottfried von Keudell; Erel Joffe Journal: J Hematol Oncol Date: 2021-01-06 Impact factor: 17.388
Authors: Sebastian Zschaeck; Bibiana Blümke; Peter Wust; David Kaul; Marcus Bahra; Hanno Riess; Fritz Klein; Marianne Sinn; Uwe Pelzer; Volker Budach; Pirus Ghadjar Journal: PLoS One Date: 2017-10-12 Impact factor: 3.240
Authors: Alexander L Chin; Sonya Aggarwal; Pooja Pradhan; Karl Bush; Rie von Eyben; Albert C Koong; Daniel T Chang Journal: Adv Radiat Oncol Date: 2018-02-21